Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hasan, Tasnim
BLAST, NCT05664568: The - 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis	Recruiting	2	30	RoW	Cephalexin, Keflex, Amoxicillin-Clavulanate 500 Mg-125 Mg Oral Tablet, Augmentin, Standard of care treatment of tuberculosis, HREZ	Western Sydney Local Health District, Centre Of Research Excellence in Tuberculosis Control	Tuberculosis, Pulmonary	07/24	12/24
HBVPOCT, NCT05144776: Evaluation of Hepatitis B Virus (HBV) DNA Test as Point of Care Tool	Recruiting	N/A	300	RoW	GeneXpert HBV DNA Viral Load Assay, Dried Blood Spot HBV DNA test	Kirby Institute	Hepatitis B	12/24	12/25
REACH-B, NCT04914611: Real World Assessment of People Living With Chronic Hepatitis B in Australia	Recruiting	N/A	10000	RoW	No intervention	Kirby Institute	Hepatitis B	07/26	07/27